Newsroom

In the News

• 08.02.2023

  BioIT World: Discovery To Creation - Highlights from the 2023 Single-Cell and AI in Medicine Symposium

• 07.27.2023

  Cellarity Recognized as a 2023 Prix Galien USA Nominee for Best Startup

• 07.05.2023

  GEN: Diverse Approaches, Common Goals Evident at Single-Cell/AI Symposium

• 06.28.2023

  Drug Target Review Q&A with Cellarity

• 06.06.2023

  Cellarity Appoints Dr. Gregory J. Moore to Board of Directors

• 04.13.2023

  Cellarity Hosts Second Single Cell and AI in Medicine Symposium on May 4, 2023

• 04.11.2023

  Cellarity Strengthens Executive Leadership Team

• 10.04.2022

  Cellarity Announces Close of $121 Million Series C Financing

• 08.17.2022

  Cellarity Releases Novel, Open-Source, Single-Cell Dataset and Invites the Machine Learning and Computational Biology Communities to Develop New Algorithms Capable of Learning Fundamental Rules of Cell Behavior

• 05.09.2022

  Cellarity Appoints Dr. Sandra Horning to Board of Directors

• 05.06.2022

  Cellarity Hosts First Single Cell and AI in Medicine Symposium on May 19

• 02.10.2022

  Cellarity Expands Leadership Team to Continue Evolution of a Breakthrough Platform to Encode Biology and Purposefully Create New Medicines

• 01.06.2022

  The Future of Biotech in an Artificially Intelligent World

• 12.08.2021

  Cellarity Appoints Biopharmaceutical Executive Ian Estepan to its Board of Directors

• 10.07.2021

  5 Up-and-Coming Biotech Startups Worth Watching

• 10.06.2021

  Decoding cell behavior and disease with AI and single-cell transcriptomics

• 09.27.2021

  Fierce Biotech names Cellarity as one of its “Fierce 15” Biotech Companies of 2021

• 02.25.2021

  Cellarity Raises $123 Million in Series B Funding to Pioneer a New Approach to Drug Discovery, Treating Disease at the Level of the Cell as Opposed to a Single Molecular Target

• 07.16.2020

  Flagship Pioneering Bolsters Executive Team with Appointment of Fabrice Chouraqui in Newly Created Dual Role of Flagship CEO-Partner and CEO of Cellarity

• 12.11.2019

  Flagship Pioneering launches Cellarity for cell behaviour-targeting drugs

• 12.11.2019

  Flagship’s Cellarity Aims to Advance Cell Behavior-Based Therapeutics

• 12.10.2019

  Flagship’s Cellarity maps out network-based drug discovery

• 12.10.2019

  Flagship Pioneering Launches New Company to Discover Medicines Targeting Cellular Behavior | BioSpace

• 12.10.2019

  Flagship Pioneering's Cellarity Exits Stealth Mode to Discover Drugs Using Cell Behavior

• 12.10.2019

  Cellarity, Flagship's $50M bet on Network Biology, Marries Machine Learning and Single-Cell Tech for Drug Discovery

• 12.10.2019

  Fierce Biotech | Flagship Company Cellarity Takes Aim at Cell Behavior

• 12.09.2019

  Flagship Pioneering Unveils Cellarity, the First Company to Discover Medicines Targeting Cell Behavior

• 10.23.2019

  Can Machines Understand Complex Biology?